Gibson Dunn has advised Cytokinetics, Incorporated. Latham & Watkins LLP has advised the underwriters. Cytokinetics, Incorporated (Nasdaq: CYTK) completed a public offering of 11,338,028 shares of...
Cytokinetics Raises $805 Million in Public Offering of Common Stock
Cytokinetics’ $540 Million Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers in the offering while Cooley advised Cytokinetics. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, has announced the pricing of its...